INTRODUCTION
A lack of insight was the most prevalent symptom of schizophrenia found in two seminal international studies, the International Pilot Study of Schizophrenia (IPSS) 1 and the Classification of Chronic Hospitalized Schizophrenics (CCHS). 2 In addition, lack of insight has been included among the 12 symptoms that have the highest power to discriminate schizophrenia from other psychoses and depression. 3 It has been shown that patients with better insight are more likely to present better adherence to treatment. 4, 5 Lack of insight has been correlated with worse outcome, 6 more admissions, 6 worse psychosocial functioning, 7, 8 reduced success rates in outpatient treatment of relapses, 9 and longer interval between the onset of symptoms and the seeking of treatment. 10 The relationship between insight and psychopathology is controversial. Some authors have proposed that insight is independent of psychopathology 11, 12 while others have found a negative correlation between insight and the general measures of psychopathology. 13 In a recent meta-analysis of 40 studies, Mintz et al. concluded that there is indeed an association between insight and psychopathology that is weak and mediated by the phase of the illness, as well as by the patient's age at onset of the symptoms. They described a negative correlation between the positive symptoms of schizophrenia and insight that is stronger among patients in the acute phase, and a negative correlation between negative symptoms and insight that is stronger among patients with late onset of symptoms. 14 Many studies have shown a positive relationship between insight and the depressive symptoms of schizophrenia. 14, 15 Insight has been found to be associated with a higher risk of suicide, 16, 17 but this finding has not been confirmed. 18 A faint correlation or no correlation at all has been described between insight and neuropsychological deficits. 11, 12, 19 A reduction in the overall size of the brain 20 and atrophy of the frontal lobe 21 have been shown among patients with insight impairment. Startup 22 suggested that a relationship between cognitive deficits and insight might only exist among some subpopulations of patients and that there might be stronger influence of psychological and sociocultural factors among those whose cognitive functions but not insight are preserved. Lysaker et al. 23 found significant evidence to support the idea that there might be two distinct groups with insight impairment: one with deficits of the executive functions, and the other with a strong tendency to use psychological mechanisms of denial of the illness. The role of psychological defenses in the formation of insight has already been recognized by some authors.
24,25
The sociocultural context
The scarcity of studies on the social and cultural influences on insight arises in spite of the large number of works on the role played by those factors in the onset, diagnosis, treatment and prognosis of schizophrenia. [26] [27] [28] According to Kirmayer 
RESULTS:
Family members performed better than patients in the total and partial SAI scores [total: 13.0 to 8.75 (p < 0.001); adherence: 3.9 to 3.4 (p < 0.005); recognition of illness: 5.5 to 3.5 (p < 0.001); relabeling of psychotic phenomena: 3.6 to 1.9 (p < 0.001)]. However, when the scores were correlated for each patient-family member pair, the only partial score that had a negative correlation was the relabeling of psychotic phenomena (r = -0.14), while the others had positive correlations (total r = 0.401; adherence r = 0.410; recognition of illness r = 0.422).
DISCUSSION:
There was a lack of correlation between the scores of family members and patients regarding the ability to relabel psychotic phenomena as abnormal. This might be understood as a smaller influence of sociocultural factors in this dimension than in other dimensions. The fact that family members were not assessed for the presence of psychopathology is a limitation of this study.
CONCLUSIONS: Different dimensions of insight are not equally influenced by disease and sociocultural factors. The recognition of illness is more strongly influenced by sociocultural factors than the ability to relabel psychotic phenomena as abnormal.
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ways to describe oneself that are specific to the culture that the individual comes from. Therefore, insight is not a mere act of the patient's self-perception that he or she is ill, but rather a construction that depends on the sociocultural context. According to Johnson and Orrell, 30 psychotic patients disagree with their doctors as to their symptoms and illness not only because they are ill, but also because they have a different concept of their experience, which is molded by their sociocultural context. There are standardized ways of thought and action for reporting the experiencing of illness that are guided by the local culture. Patients use these standards, which may differ from the physicians' standards and from those of patients from different cultures. 31, 32 Cultural influences on the self-evaluation of mental illness are found when groups of psychotic patients from different cultures are studied and compared. 33, 34 In addition to the different conceptions of mental illness, there are other important sociocultural factors. White et al. 35 found a strong association between the size of the primary group (family and close friends) and insight. They stated, as also postulated by Breier and Strauss, 36 that broader social contact exerts a normalizing function on the individual that leads to better insight.
Another sociocultural factor that could interfere in the evaluation of mental illness by patients could be stigma, which would be stronger in some specific cultures. 30 There is evidence that patients' denial of their illness could buffer the impact of the stigma on patients' self-appraisal. 37 Johnson and Orrel 30 stated that different dimensions of insight are influenced in different ways by psychosocial factors. The ability to relabel psychotic phenomena as abnormal is influenced more by psychopathological factors than by sociocultural ones. Recognition of illness is the variable most affected by the latter factors.
Evaluation of the attitude of family members regarding the illness
Angermeyer and Matschinger 38 studied family members' beliefs regarding the causes of schizophrenia, and showed that they attributed it to biological factors. This perception differed from that of the general population, for whom psychosocial factors were considered to be the most important ones. These authors considered this finding to be the result of the closer contact of family members with the treatment system, as well as their need to deal with the guilt related to the illness. However, in a study by Holzinger et al., 39 family members also considered the psychosocial causes to be the main ones. In another study, Angermeyer and Matschinger 40 came to the conclusion that personal experience with mentally ill patients led to a more positive attitude and to fewer reactions of fear.
The influence of family members on patients' insight into their illness has been investigated by some authors. Mantonakis et al. 41 found a positive relationship between negative attitudes towards persons with schizophrenia and low educational level of family members, but no relationship between negative attitudes and higher rates of relapse. Smith et al. 42 adapted the Scale to Assess Unawareness of Mental Disorder (SUMD) for use among family members, and observed that family members and patients presented similar scores. Family members' results were better in relation to the attribution of symptoms to the illness. Both groups identified a higher number of symptoms than they were able to attribute to the illness.
Measurement of insight
There are some standardized instruments designed for assessing insight. All of them approach insight from a dimensional point of view. David 43 developed the Schedule for Assessment of Insight (SAI), made up of three distinct components: (a) adherence to treatment, (b) recognition of having a mental illness and (c) ability to relabel psychotic phenomena as abnormal. This instrument was validated in a population of 63 schizophrenic patients (45 under outpatient treatment and 18 hospitalized). 44 Amador et al. 6 developed the Scale to Assess Unawareness of Mental Disorder (SUMD) comprising the general items of general awareness of having a mental disorder, awareness of the benefits of treatment and awareness of the social consequences of the disorder, in addition to two subscales for evaluating awareness and attribution for each symptom. Training is required for its administration. Fiss 45 translated it into Portuguese, adapted it to our environment and studied its reliability. Given the validation data, the brevity of the scale and the possibility of adapting it to family members, we chose to use the SAI in this work.
The objectives of this study were to: Patients who could not be interviewed because of mutism, negativism or psychomotor agitation were excluded.
One hundred and ninety-five patients were admitted during the aforementioned period; 33 were excluded because they lived outside the defined area or did not have a telephone number for contact. The remaining 162 were randomly sorted and then contacted until we achieved the target sample of 40 patient-family member pairs. One hundred and fifty-four patients were contacted to reach the final sample of 40. Out of the initial 154, 39 (25.3%) were not found (no successful contact after 3 attempts). Seventy-five patients (48.8%) were contacted, but were not included because of another diagnosis (30 patients), dropping out from treatment (18) , nonavailability of any family member (11), refusal to participate (7), referral to another treatment facility (6), or discharge (3). The 40 patients selected represented 25.9% of the total sample.
Interview and Instrument
The interviews were carried out by one psychiatrist (the first author). Demographic and clinical data were gathered and the diagnostic inclusion criteria were assessed according to the DSM-IV criteria. The evaluation of insight was carried out using the SAI, for each participant (patient and family member) separately. The scale was a translation of the scale developed by David 43 and validated in 1997. 44 The authors of the present study adapted the scale to be applied to family members of the patients (Appendix 1). The interviews were carried out over five months, between February 6, 2001, and July 10, 2001, at Projesq. Patients and family members were interviewed on the same days, except in two cases in which there were intervals of 36 and 78 days. The SAI comprises three subscales that measure distinct components of insight, namely adherence to treatment, recognition of illness and ability to relabel psychotic phenomena as abnormal. The sum of the scores of the subscales yields a total score of up to 14 points. At the end of the scale there is a supplementary question (hypothetical contradiction) that can add up to 4 points to the total score, which then would reach 18 points. The calculations showed in the results section were made without the supplementary question.
Six demographic variables were recorded for patients and family members: gender, age, ethnicity, marital status, religion and number of years of education. Eight clinical variables were recorded for patients only. These were presence, number and duration of previous hospitalizations, duration of illness, associated psychological treatment, family history of schizophrenia, suicide attempts and age at onset of illness.
Student's t test was used to compare means between the two groups. The chi-squared test was used to compare category variables, and correlations were performed using the Spearman correlation test.
This project was reviewed and approved by the ethics review committee of the Institute of Psychiatry, Faculty of Medicine, Universidade de São Paulo.
RESULTS
The demographic and clinical characteristics of the two groups are presented in Table 1 . One patient had been admitted to the psychiatric hospital and the other 39 were under outpatient treatment at the time of the interview. Regarding antipsychotic medication, 30 patients had no change during the month preceding the interview, 9 had the dos- age increased, and one had a gradual change from risperidone to clozapine.
Insight among the patients was not related to the demographic variables of age, gender and number of years of education, or to the clinical variables of age at onset of illness, duration of illness, number and duration of hospitalizations, suicide attempts (n = 12), previous hospitalization (n = 26), or family history of schizophrenia (n = 20). The patients who had the medication changed during the preceding month (n = 11) did not present significant differences in insight into their illness, compared with those who did not have it changed. The subgroup of patients who were under psychological treatment (n = 5) had better insight into the illness (t = -3.64; p = 0.004).
The mean SAI score was 8.75 (95% CI: 7.52 to 9.98) for the patients and 13.0 (95% CI: 12.42 to 13.58) for the family members. The histograms of scores for the two groups are shown in Figure 1 . Family members performed better in the total and partial SAI scores, as shown in Table 2 . However, when the scores were correlated for each patientfamily member pair, the only partial score that had a negative correlation was the relabeling of psychotic phenomena (Table 3) .
DISCUSSION
The lack of relationship between insight and the demographic variables of age, sex and number of years of education is in agreement with many previous studies. 12, 18, 21, 47 However, this finding is not unanimous. There might be better insight among male patients 5 and among patients with a higher educational level. 48 Most studies have not found associations between insight and variables such as age of onset of illness, duration of illness and number of hospitalizations over lifetime. 18, 21, 49 Others, however, have found better insight among patients with more hospitalizations, 50 longer duration of illness 48 and lower age at onset of illness. 44 The fact that patients under psychological treatment had a better insight into the illness could be due to the psychoeducation provided by psychotherapy. Another explanation could be the reduction in the denial of the illness that would play a role in insight impairment. There may also be a bias, because patients with better insight would be more amenable to psychotherapy.
Family members scored significantly higher in all the components of the scale and in the overall score. The lack of correlation between the scores of family members and patients in the ability to relabel psychotic phenomena as abnormal can possibly be understood as the effect of stronger influence of cultural factors on the first two components of insight, namely adherence to treatment and recognition of illness. On the other hand, the relabeling of psychotic phenomena may be more influenced by psychopathology. This has also been suggested by Johnson and Orrell. 30 Nevertheless, alternative explanations for this exist. The presence of schizoid personality traits is more common among family members of psychotic patients, and people with these traits could have more difficulty in identifying some symptoms of schizophrenia as such, because such symptoms may resemble these individuals' traits. 51 In addition, family members of psychotic patients also present more neuropsychological alterations than do control subjects. 52 The presence of such psychopathological and neuropsychological characteristics among family members could account for the greater difficulty in identifying schizophrenia symptoms when they are present in other members of the family.
We should stress that the adapted scale used for family members did not prove to be a good instrument for this group. The scores obtained exhibited a concentration of high values, with little variation (ceiling effect), which made it impossible to properly discriminate the insight shown by this group. A similar finding has been reported in relation to another scale, the SUMD. 42 
Limitations
Family members were not assessed for personality traits and neuropsychological deficits that could have influenced their ability to recognize schizophrenia symptoms among their relatives. With regard to the possibility of generalizing the results from this study, there was a selection bias, considering that the sample was recruited within a clinical setting. Such a sample would thus be more prone to have insight into illnesses, either as a factor influencing the seeking of treatment, or as an effect from the treatment. Further research evaluating patients and members of their families before their first contact with the treatment system could avoid such bias. Specific tools and methods have been developed to allow the diagnosis of psychiatric disorder in the general population by lay interviewers, i.e. including both those undergoing treatment and those who are not. 53 
CONCLUSION
Since patients and members of their families share the same cultural environment, the significant difference regarding their insight can possibly be better explained by disease factors. Different degrees of insight are not equally influenced by disease and sociocultural factors. The recognition of illness seems to be more strongly influenced by sociocultural factors than is the ability to relabel psychotic phenomena as abnormal.
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